These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10204591)

  • 1. Frequency of immediate adverse effects associated with therapeutic apheresis.
    McLeod BC; Sniecinski I; Ciavarella D; Owen H; Price TH; Randels MJ; Smith JW
    Transfusion; 1999 Mar; 39(3):282-8. PubMed ID: 10204591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic apheresis: results from a single center in Turkey.
    Yavasoglu I; Kadikoylu G; Akyol A; Bolaman Z
    Transfus Apher Sci; 2007 Jun; 36(3):249-53. PubMed ID: 17556022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.
    Howell C; Douglas K; Cho G; El-Ghariani K; Taylor P; Potok D; Rintala T; Watkins S
    Transfus Med; 2015 Apr; 25(2):57-78. PubMed ID: 26013470
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of apheresis in children.
    Michon B; Moghrabi A; Winikoff R; Barrette S; Bernstein ML; Champagne J; David M; Duval M; Hume HA; Robitaille N; Bélisle A; Champagne MA
    Transfusion; 2007 Oct; 47(10):1837-42. PubMed ID: 17880609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of hemapheresis practice in Turkey (1998).
    Ilhan O; Uskent N; Arslan O; Arat M; Ozkalemkaş F; Oztürk G; Kalayoglu SB; Ozet A; Tombuloglu M; Arpaci F; Ovali E; Anak S
    Transfus Sci; 2000 Jun; 22(3):195-201. PubMed ID: 10831922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry.
    Norda R; Berséus O; Stegmayr B
    Transfus Apher Sci; 2001 Aug; 25(1):33-41. PubMed ID: 11791760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAA apheresis registry in the Czech Republic: two centers experience.
    Bláha M; Pták J; Cáp J; Ceeová V; Masín V; Filip S; Blazek M
    Transfus Apher Sci; 2009 Aug; 41(1):27-31. PubMed ID: 19524488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events during apheresis: A 10-year experience at a tertiary academic medical center.
    Kundrapu S; Datla S; Griffin V; Maitta RW
    J Clin Apher; 2019 Oct; 34(5):528-536. PubMed ID: 30951224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apheresis activity in Venezuela.
    Saltiel C
    J Clin Apher; 2005 Jul; 20(2):95-100. PubMed ID: 15880361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Italian SIdEM registry for apheresis: an overview of the 2005 statistics.
    De Silvestro G; Bagatella P; Vicarioto M; Tison T; Marson P
    Int J Artif Organs; 2008 Apr; 31(4):354-62. PubMed ID: 18432593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasovagal reactions in apheresis donors.
    Tomita T; Takayanagi M; Kiwada K; Mieda A; Takahashi C; Hata T
    Transfusion; 2002 Dec; 42(12):1561-6. PubMed ID: 12473135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of 516 reports of reactions after the transfusion of labile blood products].
    Frère MC; Rapaille A; Bouillenne C; Gérard C; Sondag D; Verhees A
    Transfus Clin Biol; 2001 Aug; 8(4):333-42. PubMed ID: 11642025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events in therapeutic apheresis: a single center survey of various therapies.
    Ishihara T; Inoue S; Takagi Y; Shimomura T; Sagami Y; Katayama S; Eguchi Y; Watase K; Miyamoto M; Minakata T
    Ther Apher Dial; 2010 Dec; 14(6):589-95. PubMed ID: 21118368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.
    Yuan S; Ziman A; Smeltzer B; Lu Q; Goldfinger D
    Transfusion; 2010 Feb; 50(2):478-86. PubMed ID: 19843285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World apheresis registry report.
    Stegmayr B; Ptak J; Wikström B
    Transfus Apher Sci; 2007 Feb; 36(1):13-6. PubMed ID: 17234456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in apheresis: An update of the WAA registry data.
    Mörtzell Henriksson M; Newman E; Witt V; Derfler K; Leitner G; Eloot S; Dhondt A; Deeren D; Rock G; Ptak J; Blaha M; Lanska M; Gasova Z; Hrdlickova R; Ramlow W; Prophet H; Liumbruno G; Mori E; Griskevicius A; Audzijoniene J; Vrielink H; Rombout S; Aandahl A; Sikole A; Tomaz J; Lalic K; Mazic S; Strineholm V; Brink B; Berlin G; Dykes J; Toss F; Axelsson CG; Stegmayr B; Nilsson T; Norda R; Knutson F; Ramsauer B; Wahlström A
    Transfus Apher Sci; 2016 Feb; 54(1):2-15. PubMed ID: 26776481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.